吗丁啉品牌怎么样 申请店铺

我要投票 吗丁啉在保健药品行业中的票数:117 更新时间:2025-02-05
吗丁啉是哪个国家的品牌?「吗丁啉」是 西安杨森制药有限公司 旗下著名品牌。该品牌发源于陕西,由创始人ASGAR DAVID RANGOONWALA在1985期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
吗丁啉怎么样


【吗丁啉®】用于消化不良、腹胀、嗳气、恶心、呕吐、腹部胀痛。口服。成人一次1片,一日3次,饭前15-30分钟服用。本品为胃肠促动力药非处方药药品。请仔细阅读说明书并按说明使用或在药师指导下购买和使用。

成立于1985年的西安杨森制药有限公司,是美国强生公司在华最大的子公司,也是中国最大的合资制药企业之一。生产基地位于西安,在全国28个城市设有办事处,在华员工超过3,000人。

公司业务包括生产和销售高质量的药品,产品主要涉及胃肠病学、神经精神学、变态反应学、疼痛管理学、抗感染、生物制剂和肿瘤等领域;除此之外,公司还致力于提供与健康相关的服务及开展大众健康教育。

西安杨森制药有限公司着眼于未来,不断引进新的药品,并努力提高中国的医疗卫生水平,以服务广大的中国患者。

西安杨森工厂位于历史悠久的古城西安,是中国西北地区最早建立的中外合资制药企业的工厂。它占地170亩,建筑面积35,620平米,绿化面积约占52%。主要建筑物包括制剂车间、动力运行、污水处理中心、行政办公楼、综合办公楼、员工餐厅等。

西安杨森工厂在生产及管理上均达到了中国和欧洲的药品生产质量管理规范(GMP)的标准,达到了国际标准化组织ISO9001:2000标准质量管理体系及ISO14001标准环境管理体系要求,达到了OHSAS职业安全健康管理体系的要求,这些有利于西安杨森与国外在提供产品与服务方面的交流。同时,西安杨森工厂还采用国际通行的现代企业管理制度,引进了SAP系统进行战略和运营管理,以世界级的生产设备、高科技的检测技术、严密的质量体系、卓越的国际物流系统,完成从原材料进厂、制造、包装到成品检验出厂的全过程,并对所有环节均进行严格地质量监控。稳固、高效的供应链系统,严谨、流畅的生产系统,高效、安全的国际化配送系统,以及严格、稹密的质量保证系统,已经使西安杨森工厂成为了全球的国际化的生产中心。这里生产的产品剂型有片剂、胶囊剂、乳膏剂、液剂、栓剂和散剂,包装类型有管装、瓶装、袋装和铝塑包装。

1997年,西安杨森工厂率先通过国家药品GMP认证。1999年,获得德国莱茵公司ISO9002质量管理体系认证。2003年完成ISO9001:2000升级认证。2004年10月和2007年9月,西安杨森工厂顺利通过了欧盟GMP审计署的首次审核和再次审核,标志着我们的厂房、设备、环境、人员、文件体系及质量管理体系完全符合欧洲GMP的标准,同时也保证了西安杨森在医药领域的先进性与国际化。

为了更好地服务于客户,西安杨森还在工厂建立了一个跨部门协作中心――客户关爱中心(CustomerCareCenter,简称CCC),设立24小时热线,随时倾听来自客户的声音,及时处理与反馈客户咨询及投诉。客户关爱中心人员具备医学、药学背景和专业知识的培训,在沟通互动中不仅传递专业信息,同时也将强生信条中“对客户负责”的理念以实际行动传递给了客户,从而赢得了客户赞誉,并赢得未来。

相关链接:【吗丁啉®】药品说明>>


[morpholine ®] is used for dyspepsia, abdominal distention, belching, nausea, vomiting, abdominal distention and pain. Oral administration. Adults take one tablet three times a day 15-30 minutes before meals. This is an over-the-counter drug for gastrointestinal motility. Please read the manual carefully and use it according to the instructions or purchase and use it under the guidance of pharmacist. Founded in 1985, Xi'an Janssen Pharmaceutical Co., Ltd. is the largest subsidiary of Johnson & Johnson in China and one of the largest pharmaceutical joint ventures in China. The production base is located in Xi'an, with offices in 28 cities and more than 3000 employees in China. The company's business includes the production and sale of high-quality drugs. Its products mainly involve Gastroenterology, neuropsychology, allergy, pain management, anti infection, biological agents and tumors. In addition, the company is committed to providing health-related services and developing public health education. Xi'an YANGSEN Pharmaceutical Co., Ltd. focuses on the future, constantly introduces new drugs, and strives to improve China's medical and health level to serve the vast number of Chinese patients. Located in the ancient city of Xi'an with a long history, Xi'an Janssen factory is the first Sino foreign joint venture pharmaceutical enterprise in Northwest China. It covers an area of 170 mu, with a building area of 35620 square meters and a greening area of about 52%. The main buildings include preparation workshop, power operation, sewage treatment center, administrative office building, comprehensive office building, staff restaurant, etc. In terms of production and management, Xi'an Janssen factory has reached the GMP standards of China and Europe, the ISO 9001:2000 standard quality management system and ISO14001 standard environmental management system, and the OHSAS occupational safety and health management system, which are conducive to the products and services provided by Xi'an Janssen and foreign countries Face to face communication. At the same time, Xi'an Janssen plant also adopts the internationally accepted modern enterprise management system and introduces SAP system for strategic and operational management. With world-class production equipment, high-tech testing technology, strict quality system and excellent international logistics system, it completes the whole process from raw material entering the plant, manufacturing, packaging to finished product inspection and leaving the factory, and strictly carries out all links Ground quality monitoring. A stable and efficient supply chain system, a rigorous and smooth production system, an efficient and safe international distribution system, and a strict and strict quality assurance system have made Xi'an YANGSEN factory a global international production center. The products produced here are tablets, capsules, creams, liquids, suppositories and powders. The packaging types include tube, bottle, bag and aluminum plastic packaging. In 1997, Xi'an Janssen factory took the lead in passing the national GMP certification. In 1999, it obtained the ISO9002 quality management system certification of German Rhine company. In 2003, ISO9001:2000 upgrade certification was completed. In October 2004 and September 2007, the Xi'an Yang Sen factory successfully passed the first audit and re examination of the GMP Audit Office of the European Union, marking that our factory buildings, equipment, environment, personnel, file system and quality management system fully comply with the European GMP standard, and also guaranteed the advanced nature and internationalization of Yang Sen in the field of medicine in Xi'an. In order to better serve customers, Xi'an Janssen has also established a cross department cooperation center customer care center (CCC) in the factory. It has set up a 24-hour hotline to listen to the voice from customers at any time, handle and feedback customer consultation and complaints in a timely manner. The staff of the customer care center have the training of medical and pharmaceutical background and professional knowledge. In the communication and interaction, they not only pass the professional information, but also pass the concept of "being responsible for customers" in Johnson's creed to the customers with practical actions, so as to win the praise of customers and win the future. Related links: [domperidone ®] Drug Description & gt; & gt;

本文链接: https://brand.waitui.com/5009730e4.html 联系电话:82576688

千城特选小程序码

7×24h 快讯

九洲药业:子公司浙江瑞博通过美国FDA现场检查

36氪获悉,九洲药业公告,公司子公司浙江瑞博制药有限公司于2024年10月28日至2024年11月1日期间接受了美国食品药品监督管理局的cGMP现场检查,检查范围涵盖质量体系、物料、生产、包装与标签、设备设施、实验室控制六大系统。近日,浙江瑞博收到美国FDA签发的现场检查报告(EIR,Establishment Inspection Report),该报告表明浙江瑞博已通过本次cGMP现场检查。检查范围为浙江瑞博涉及产品(非无菌原料药卡马西平、文拉法辛苯磺酸盐 —水合物以及药物中间体沙库巴曲)的生产制造。

2小时前

美图:公司旗下产品采用了DeepSeek技术

36氪获悉,据摩根士丹利透露,美图公司旗下的美图设计室已采用DeepSeek技术,主要为AI生成PPT相关功能。

2小时前

硅业分会:多晶硅企业年后集中签单在即,硅料环节持续去库

36氪获悉,据中国有色金属工业协会硅业分会消息,本周逢春节假期,多晶硅企业整体暂无规模性签单,多晶硅市场价格维持稳定。n型复投料成交价格区间为3.90-4.50万元/吨,成交均价为4.17万元/吨,n型颗粒硅成交价格区间为3.80-4.10万元/吨,成交均价为3.90万元/吨,p型多晶硅成交价区间为3.20-3.60万元/吨,成交均价为3.40万元/吨。本周多晶硅企业正常执行前期订单,年后订单仍在洽谈中。目前下游硅片企业排产有上调预期,对多晶硅需求量稳步增长。

2小时前

传宁德时代考虑提交香港上市申请,官方暂无回应

今日有消息称,宁德时代据称考虑在未来几周提交香港上市申请。针对此事,宁德时代方面暂无回应。此前,2024年底也有外媒报道称,宁德时代考虑最快于2025年在香港上市,筹集至少50亿美元。(新浪科技)

2小时前

华泰股份:股票连续12个月收盘价均低于每股净资产,公司制定估值提升计划

36氪获悉,华泰股份公告,公司股票连续12个月每个交易日收盘价均低于最近一个会计年度经审计的每股归属于公司普通股股东的净资产,根据《上市公司监管指引第10号——市值管理》的相关规定,华泰股份制定估值提升计划。公司估值提升计划已经公司第十一届董事会第四次会议审议通过。华泰股份估值提升计划将围绕生产经营、现金分红、股份回购、股东增持、投资者关系管理以及信息披露等方面。

2小时前

本页详细列出关于兴卫医药的品牌信息,含品牌所属公司介绍,兴卫医药所处行业的品牌地位及优势。
咨询